Compartir
array:23 [
"pii" => "S1699258X18301347"
"issn" => "1699258X"
"doi" => "10.1016/j.reuma.2018.07.002"
"estado" => "S300"
"fechaPublicacion" => "2020-07-01"
"aid" => "1248"
"copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
"copyrightAnyo" => "2018"
"documento" => "article"
"crossmark" => 1
"subdocumento" => "fla"
"cita" => "Reumatol Clin. 2020;16:282-5"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 510
"formatos" => array:3 [
"EPUB" => 34
"HTML" => 368
"PDF" => 108
]
]
"itemSiguiente" => array:19 [
"pii" => "S1699258X18302195"
"issn" => "1699258X"
"doi" => "10.1016/j.reuma.2018.09.005"
"estado" => "S300"
"fechaPublicacion" => "2020-07-01"
"aid" => "1282"
"copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
"documento" => "simple-article"
"crossmark" => 1
"subdocumento" => "crp"
"cita" => "Reumatol Clin. 2020;16:286-9"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 7
"formatos" => array:2 [
"HTML" => 4
"PDF" => 3
]
]
"es" => array:12 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original breve</span>"
"titulo" => "Prevalencia y características demográficas del síndrome de Sjögren en Colombia, según información del Sistema Integral de Información de la Protección Social"
"tienePdf" => "es"
"tieneTextoCompleto" => "es"
"tieneResumen" => array:2 [
0 => "es"
1 => "en"
]
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "286"
"paginaFinal" => "289"
]
]
"titulosAlternativos" => array:1 [
"en" => array:1 [
"titulo" => "Prevalence and Demographic Characteristics of Sjögren's Syndrome in Colombia, Based on Information from the Official Ministry of Health Registry"
]
]
"contieneResumen" => array:2 [
"es" => true
"en" => true
]
"contieneTextoCompleto" => array:1 [
"es" => true
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "Daniel G. Fernández-Ávila, Diana N. Rincón-Riaño, Santiago Bernal-Macías, Juan M. Gutiérrez Dávila, Diego Rosselli"
"autores" => array:5 [
0 => array:2 [
"nombre" => "Daniel G."
"apellidos" => "Fernández-Ávila"
]
1 => array:2 [
"nombre" => "Diana N."
"apellidos" => "Rincón-Riaño"
]
2 => array:2 [
"nombre" => "Santiago"
"apellidos" => "Bernal-Macías"
]
3 => array:2 [
"nombre" => "Juan M."
"apellidos" => "Gutiérrez Dávila"
]
4 => array:2 [
"nombre" => "Diego"
"apellidos" => "Rosselli"
]
]
]
]
]
"idiomaDefecto" => "es"
"Traduccion" => array:1 [
"en" => array:9 [
"pii" => "S2173574320300800"
"doi" => "10.1016/j.reumae.2018.09.016"
"estado" => "S300"
"subdocumento" => ""
"abierto" => array:3 [
"ES" => false
"ES2" => false
"LATM" => false
]
"gratuito" => false
"lecturas" => array:1 [
"total" => 0
]
"idiomaDefecto" => "en"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320300800?idApp=UINPBA00004M"
]
]
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18302195?idApp=UINPBA00004M"
"url" => "/1699258X/0000001600000004/v1_202007040724/S1699258X18302195/v1_202007040724/es/main.assets"
]
"itemAnterior" => array:19 [
"pii" => "S1699258X18301360"
"issn" => "1699258X"
"doi" => "10.1016/j.reuma.2018.07.004"
"estado" => "S300"
"fechaPublicacion" => "2020-07-01"
"aid" => "1250"
"copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
"documento" => "article"
"crossmark" => 1
"subdocumento" => "fla"
"cita" => "Reumatol Clin. 2020;16:272-81"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 741
"formatos" => array:3 [
"EPUB" => 35
"HTML" => 572
"PDF" => 134
]
]
"es" => array:12 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
"titulo" => "Recomendaciones de experto sobre el bloqueo de la interleucina 6 en pacientes con artritis reumatoide"
"tienePdf" => "es"
"tieneTextoCompleto" => "es"
"tieneResumen" => array:2 [
0 => "es"
1 => "en"
]
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "272"
"paginaFinal" => "281"
]
]
"titulosAlternativos" => array:1 [
"en" => array:1 [
"titulo" => "Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis"
]
]
"contieneResumen" => array:2 [
"es" => true
"en" => true
]
"contieneTextoCompleto" => array:1 [
"es" => true
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "Jesús Tornero Molina, Alejandro Balsa Criado, Francisco Blanco García, Ricardo Blanco Alonso, Sagrario Bustabad, Jaime Calvo Alen, Héctor Corominas, Antonio Fernández Nebro, Jose Andrés Román Ivorra, Raimon Sanmartí"
"autores" => array:10 [
0 => array:2 [
"nombre" => "Jesús"
"apellidos" => "Tornero Molina"
]
1 => array:2 [
"nombre" => "Alejandro"
"apellidos" => "Balsa Criado"
]
2 => array:2 [
"nombre" => "Francisco"
"apellidos" => "Blanco García"
]
3 => array:2 [
"nombre" => "Ricardo"
"apellidos" => "Blanco Alonso"
]
4 => array:2 [
"nombre" => "Sagrario"
"apellidos" => "Bustabad"
]
5 => array:2 [
"nombre" => "Jaime"
"apellidos" => "Calvo Alen"
]
6 => array:2 [
"nombre" => "Héctor"
"apellidos" => "Corominas"
]
7 => array:2 [
"nombre" => "Antonio"
"apellidos" => "Fernández Nebro"
]
8 => array:2 [
"nombre" => "Jose Andrés"
"apellidos" => "Román Ivorra"
]
9 => array:2 [
"nombre" => "Raimon"
"apellidos" => "Sanmartí"
]
]
]
]
]
"idiomaDefecto" => "es"
"Traduccion" => array:1 [
"en" => array:9 [
"pii" => "S2173574319301212"
"doi" => "10.1016/j.reumae.2018.07.007"
"estado" => "S300"
"subdocumento" => ""
"abierto" => array:3 [
"ES" => false
"ES2" => false
"LATM" => false
]
"gratuito" => false
"lecturas" => array:1 [
"total" => 0
]
"idiomaDefecto" => "en"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574319301212?idApp=UINPBA00004M"
]
]
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18301360?idApp=UINPBA00004M"
"url" => "/1699258X/0000001600000004/v1_202007040724/S1699258X18301360/v1_202007040724/es/main.assets"
]
"en" => array:18 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
"titulo" => "The HLA-B*51 Allele is strongly associated with Behçet Disease in an Argentinean population"
"tieneTextoCompleto" => true
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "282"
"paginaFinal" => "285"
]
]
"autores" => array:1 [
0 => array:4 [
"autoresLista" => "Sebastián Andrés Muñoz, Alberto Omar Orden, Alex Kostianovsky, Cecilia N. Pisoni, Marina Scolnik, Aurelia Luissi, Yanina Bottinelli, Gustavo Vijoditz, Mercedes Garcia, Claudia Pena, Mariana Pera, Oscar Rillo, Teresita Alvarellos, Luciana M. Más, Arturo Luis Trunzo, Alberto Allievi"
"autores" => array:16 [
0 => array:3 [
"nombre" => "Sebastián Andrés"
"apellidos" => "Muñoz"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
]
]
1 => array:3 [
"nombre" => "Alberto Omar"
"apellidos" => "Orden"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
2 => array:3 [
"nombre" => "Alex"
"apellidos" => "Kostianovsky"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">c</span>"
"identificador" => "aff0015"
]
]
]
3 => array:3 [
"nombre" => "Cecilia N."
"apellidos" => "Pisoni"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">c</span>"
"identificador" => "aff0015"
]
]
]
4 => array:3 [
"nombre" => "Marina"
"apellidos" => "Scolnik"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">d</span>"
"identificador" => "aff0020"
]
]
]
5 => array:3 [
"nombre" => "Aurelia"
"apellidos" => "Luissi"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">d</span>"
"identificador" => "aff0020"
]
]
]
6 => array:3 [
"nombre" => "Yanina"
"apellidos" => "Bottinelli"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">e</span>"
"identificador" => "aff0025"
]
]
]
7 => array:3 [
"nombre" => "Gustavo"
"apellidos" => "Vijoditz"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">e</span>"
"identificador" => "aff0025"
]
]
]
8 => array:3 [
"nombre" => "Mercedes"
"apellidos" => "Garcia"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">f</span>"
"identificador" => "aff0030"
]
]
]
9 => array:3 [
"nombre" => "Claudia"
"apellidos" => "Pena"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">f</span>"
"identificador" => "aff0030"
]
]
]
10 => array:3 [
"nombre" => "Mariana"
"apellidos" => "Pera"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">f</span>"
"identificador" => "aff0030"
]
]
]
11 => array:3 [
"nombre" => "Oscar"
"apellidos" => "Rillo"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">g</span>"
"identificador" => "aff0035"
]
]
]
12 => array:3 [
"nombre" => "Teresita"
"apellidos" => "Alvarellos"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">h</span>"
"identificador" => "aff0040"
]
]
]
13 => array:3 [
"nombre" => "Luciana M."
"apellidos" => "Más"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">h</span>"
"identificador" => "aff0040"
]
]
]
14 => array:3 [
"nombre" => "Arturo Luis"
"apellidos" => "Trunzo"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">i</span>"
"identificador" => "aff0045"
]
]
]
15 => array:4 [
"nombre" => "Alberto"
"apellidos" => "Allievi"
"email" => array:1 [
0 => "beto.allievi@gmail.com"
]
"referencia" => array:2 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">j</span>"
"identificador" => "aff0050"
]
1 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">*</span>"
"identificador" => "cor0005"
]
]
]
]
"afiliaciones" => array:10 [
0 => array:3 [
"entidad" => "Hospital General de Agudos Dr. Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "a"
"identificador" => "aff0005"
]
1 => array:3 [
"entidad" => "Clínica San Camilo, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "b"
"identificador" => "aff0010"
]
2 => array:3 [
"entidad" => "Hospital Universitario CEMIC, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "c"
"identificador" => "aff0015"
]
3 => array:3 [
"entidad" => "Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "d"
"identificador" => "aff0020"
]
4 => array:3 [
"entidad" => "Hospital Nacional Dr. Alejandro Posadas, Ciudad del Palomar, Provincia de Buenos Aires, Argentina"
"etiqueta" => "e"
"identificador" => "aff0025"
]
5 => array:3 [
"entidad" => "Hospital General José de San Martín, Ciudad de La Plata, Provincia de Buenos Aires, Argentina"
"etiqueta" => "f"
"identificador" => "aff0030"
]
6 => array:3 [
"entidad" => "Hospital General de Agudos Dr. Ignacio Pirovano, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "g"
"identificador" => "aff0035"
]
7 => array:3 [
"entidad" => "Hospital Privado Universitario de Córdoba, Ciudad de Córdoba, Provincia de Córdoba, Argentina"
"etiqueta" => "h"
"identificador" => "aff0040"
]
8 => array:3 [
"entidad" => "Instituto Nacional Central Único Coordinador de Ablación e Implante (INCUCAI), Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "i"
"identificador" => "aff0045"
]
9 => array:3 [
"entidad" => "Medicina, Universidad del Salvador, Ciudad Autónoma de Buenos Aires, Argentina"
"etiqueta" => "j"
"identificador" => "aff0050"
]
]
"correspondencia" => array:1 [
0 => array:3 [
"identificador" => "cor0005"
"etiqueta" => "⁎"
"correspondencia" => "Corresponding author."
]
]
]
]
"titulosAlternativos" => array:1 [
"es" => array:1 [
"titulo" => "El alelo HLA-B*51 se asoció fuertemente a la Enfermedad de Behçet en la población argentina"
]
]
"textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Behçet disease (BD) is a systemic inflammatory disease of unknown etiology. It is characterized by recurrent oral aphthous and genital ulcers, uveitis, and skin lesions. Vascular injury, hyper-coagulability, hyper-function of neutrophils, and autoimmune response are pathological findings of the disease.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">BD is a complex clinical entity where genetic and environmental factors influence disease’ susceptibility. Several previous studies showed that immunogenetics factors (mainly HLA class A and B) are present in the development of BD.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">HLA-B*51 allele is the most strongly associated genetic risk factor linked with BD.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">1,2,4–6</span></a> This association is present along different geographical regions and ethnic groups.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">7</span></a> So far, two studies from Mexico are the only evidence on the association between the HLA-B51 allele and BD in Latin American countries; however, the results are contradictory.<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">8,9</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The aim of this study was to assess the association between BD and the HLA-B*51 allele in Argentinean patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Materials and Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Study Design and Setting</span><p id="par0025" class="elsevierStylePara elsevierViewall">We carried out a case–control study. The researchers who participated in the study work in reference Hospitals, and they belong to the Vasculitis Study Group of the Argentinean Society of Rheumatology.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Participants</span><p id="par0030" class="elsevierStylePara elsevierViewall">Thirty-four consecutive BD Argentinean patients were included for the study between October 2016 and March 2017. All of them had a definitive diagnosis of BD according to the International Study Group for Behçet Disease criteria, and they did not have the HLA-B*51 allele determined at study entry.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">10</span></a> Unrelated controls (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>240), and their HLA-B*51 status, were randomly obtained from the cadaveric donor database from the “<span class="elsevierStyleItalic">Instituto Nacional Central Único Coordinador de Ablación e Implante del Ministerio de Salud de La Nación (INCUCAI)”</span> the official national institution for transplant allocation in Argentina.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Variables</span><p id="par0035" class="elsevierStylePara elsevierViewall">Demographic and clinical features of the patients were recorded by attending physicians through a questionnaire. Ethnicity was defined according to definitions made by the “<span class="elsevierStyleItalic">Grupo Latinoamericano de Estudio del Lupus (GLADEL)”</span>.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">11</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">HLA Class I Typing</span><p id="par0040" class="elsevierStylePara elsevierViewall">For cases HLA class I typing was performed using a polymerase chain reaction sequence-specific oligonucleotide (PCR-SSO) coupled with a Luminex platform using a medium resolution LABType SSO class I B locus typing test (One Lambda Inc., California, USA) according to the manufacturer's instructions. The controls were typed by a PCR with sequence-specific primers (PCR-SSP).</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Statistical Analysis</span><p id="par0045" class="elsevierStylePara elsevierViewall">Descriptive statistics including percentages, mean, standard deviation (SD), median and range were calculated. The frequencies of the alleles and genotypes among patients and controls were compared by chi-squared tests. Odds ratios and 95% confidence intervals were calculated. A <span class="elsevierStyleItalic">p</span> level of ≤0.05 was considered significant in all analysis. Statistical analysis was done using Stata 14.0 (StataCorp 2015, TX, USA).</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Ethics Approval</span><p id="par0050" class="elsevierStylePara elsevierViewall">The study was approved by all local ethical committees of the corresponding hospitals, and all the study participants gave their written informed consent to participate. The research methods were in compliance of the tenets of the Declarations of Helsinki.</p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Results</span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Demographics and Clinical Features</span><p id="par0055" class="elsevierStylePara elsevierViewall">Main demographic characteristics are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. BD was slightly more prevalent in males, with a mean age at diagnosis of 35 years old. Mestizo population accounted for the majority of ethnicity, followed by White and Amerindians subjects. Most frequent clinical manifestations were oral and genital ulcers, followed by cutaneous, articular, ocular, and neurological involvement.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">HLA-B*51 Gene Distribution</span><p id="par0060" class="elsevierStylePara elsevierViewall">Out of 34 patients with BD, 13 (38.2%) of them were positive for the HLA-B*51 allele; 11 (32.3%) were heterozygous and 2 (5.8%) were homozygous. In the control group, 34 out of 240 subjects had the HLA-B*51 allele (14.2%). None of the controls were homozygous for the allele HLA-B*51. The association between BD and HLA-B*51 allele was greater than that of control group (OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3.75; 95%IC<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.71–8.19; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0012) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Discussion</span><p id="par0065" class="elsevierStylePara elsevierViewall">The most significant finding in our study is a strong association between HLA-B*51 allele and Behçet disease in Argentinean patients. This association is well known in patients belonging to Asian and Eurasian populations from Japan to the Middle East.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">7</span></a> However, there is less data on Caucasian patients with BD from other regions, such as North Western Europe and North America.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">12–16</span></a> Furthermore, there are two Latin American studies focusing on the association between HLA-B*5 allele and BD. Lavalle, et al. found that the HLA-B*5 allele was more frequent in Mexican Mestizo patients with BD than ethnically matched controls (70% vs. 31%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05).<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">8</span></a> On the other hand, Soto Vega et al., found no association between HLA-B*51 allele and BD among Mexican Mestizo patients and controls [9% vs. 5%, OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.88 (95%CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.58–5.93, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.24)].<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">9</span></a><a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows the HLA-B*51 allele frequencies in our BD patients and the Mexican Mestizo patients from Soto Vega study.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">In our study the frequency of the HLA-B*51 allele in BD patients was 38.2% as compared to 14.2% in controls. Strikingly, our data are quite similar to the pooled prevalence estimated for HLA-B*51 allele in the Northern/Eastern regions of Europe (BD<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>39%; 95%CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>28.2–51.1 vs. controls<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>11.2%; 95%CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>8.1–15.3) and North America (BD<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>34.2%; 95%CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6.0–80.8 vs. controls<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>18%; 95%CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>7.6–37.1), but lower than the pooled prevalence estimated in the Southern Europe (BD<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>60.6%; 95% CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>51.9–68.7 vs. controls<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>16.8%; 95% CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13.3–21.0) where the biggest proportion of Argentine immigration comes from.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">7</span></a> This finding could be partially explained by the fact that our studied population was predominantly Mestizo, a mixture of European (Caucasian) and native ancestors (Amerindians). Two studies showed low prevalence of HLA-B*51 in Amerindian tribes of South America (mainly Argentine natives). Fernandez-Viña et al.,<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">17</span></a> analyzed the prevalence of HLA antigens in a Toba tribe, finding an HLA-B*51 allele frequency of 3%. Parham et al.,<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">18</span></a> studied the prevalence of HLA antigen in a Guarani tribe, finding an HLA-B*51 allele frequency of 6.6%. Therefore, we assume that the admixture between European and South American Amerindian could explain that mixed populations have more HLA class I allele diversity than each ethnic group separately.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Limitations</span><p id="par0075" class="elsevierStylePara elsevierViewall">Our study has limitations. Classical case-control studies designed to evaluate gene association are exposed to bias due to the existence of population substructures that cannot be certainly determined. It is possible that our cases are not representative of all BD patients from an Argentinean population as a consequence of a selection bias. Finally, as we did not have the sex and ethnicity data of the controls, we could not match both groups for these variables.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Conclusions</span><p id="par0080" class="elsevierStylePara elsevierViewall">The HLA-B*51 allele is strongly associated with BD in Argentinean patients. Individuals carrying HLA B*51 allele have a 4-fold susceptibility risk increase of BD compared to non-carrier individuals of the allele. Our finding is consistent with previous studies indicating that the HLA-B*51 allele is an important susceptibility gene in BD regardless the geographical region and ethnicity.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Funding</span><p id="par0085" class="elsevierStylePara elsevierViewall">This research was funded by an Argentinean Rheumatology Society grant.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conflicts of Interest</span><p id="par0090" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>"
"textoCompletoSecciones" => array:1 [
"secciones" => array:13 [
0 => array:3 [
"identificador" => "xres1358135"
"titulo" => "Abstract"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0005"
"titulo" => "Objective"
]
1 => array:2 [
"identificador" => "abst0010"
"titulo" => "Methods"
]
2 => array:2 [
"identificador" => "abst0015"
"titulo" => "Results"
]
3 => array:2 [
"identificador" => "abst0020"
"titulo" => "Conclusions"
]
]
]
1 => array:2 [
"identificador" => "xpalclavsec1249071"
"titulo" => "Keywords"
]
2 => array:3 [
"identificador" => "xres1358134"
"titulo" => "Resumen"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0025"
"titulo" => "Objetivo"
]
1 => array:2 [
"identificador" => "abst0030"
"titulo" => "Métodos"
]
2 => array:2 [
"identificador" => "abst0035"
"titulo" => "Resultados"
]
3 => array:2 [
"identificador" => "abst0040"
"titulo" => "Conclusiones"
]
]
]
3 => array:2 [
"identificador" => "xpalclavsec1249072"
"titulo" => "Palabras clave"
]
4 => array:2 [
"identificador" => "sec0005"
"titulo" => "Introduction"
]
5 => array:3 [
"identificador" => "sec0010"
"titulo" => "Materials and Methods"
"secciones" => array:6 [
0 => array:2 [
"identificador" => "sec0015"
"titulo" => "Study Design and Setting"
]
1 => array:2 [
"identificador" => "sec0020"
"titulo" => "Participants"
]
2 => array:2 [
"identificador" => "sec0025"
"titulo" => "Variables"
]
3 => array:2 [
"identificador" => "sec0030"
"titulo" => "HLA Class I Typing"
]
4 => array:2 [
"identificador" => "sec0035"
"titulo" => "Statistical Analysis"
]
5 => array:2 [
"identificador" => "sec0040"
"titulo" => "Ethics Approval"
]
]
]
6 => array:3 [
"identificador" => "sec0045"
"titulo" => "Results"
"secciones" => array:2 [
0 => array:2 [
"identificador" => "sec0050"
"titulo" => "Demographics and Clinical Features"
]
1 => array:2 [
"identificador" => "sec0055"
"titulo" => "HLA-B*51 Gene Distribution"
]
]
]
7 => array:2 [
"identificador" => "sec0060"
"titulo" => "Discussion"
]
8 => array:2 [
"identificador" => "sec0065"
"titulo" => "Limitations"
]
9 => array:2 [
"identificador" => "sec0070"
"titulo" => "Conclusions"
]
10 => array:2 [
"identificador" => "sec0075"
"titulo" => "Funding"
]
11 => array:2 [
"identificador" => "sec0080"
"titulo" => "Conflicts of Interest"
]
12 => array:1 [
"titulo" => "<span class="elsevierStyleBold">References</span>"
]
]
]
"pdfFichero" => "main.pdf"
"tienePdf" => true
"fechaRecibido" => "2018-04-06"
"fechaAceptado" => "2018-07-02"
"PalabrasClave" => array:2 [
"en" => array:1 [
0 => array:4 [
"clase" => "keyword"
"titulo" => "Keywords"
"identificador" => "xpalclavsec1249071"
"palabras" => array:6 [
0 => "Systemic vasculitis"
1 => "Behçet's disease"
2 => "HLA-B antigen"
3 => "HLA-B51 antigen"
4 => "Case–control studies"
5 => "Latin America"
]
]
]
"es" => array:1 [
0 => array:4 [
"clase" => "keyword"
"titulo" => "Palabras clave"
"identificador" => "xpalclavsec1249072"
"palabras" => array:6 [
0 => "Vasculitis sistémicas"
1 => "Enfermedad de Behçet"
2 => "Antígeno HLA-B"
3 => "Antígeno HLA-B51"
4 => "Estudios de casos controles"
5 => "Latinoamericanos"
]
]
]
]
"tieneResumen" => true
"resumen" => array:2 [
"en" => array:3 [
"titulo" => "Abstract"
"resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To assess the association between the HLA-B*51 allele and Behçet Disease (BD) in Argentinean patients.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We enrolled 34 consecutive Argentinean patients with definitive diagnosis of BD between October 2016 and March 2017. None of the patients had the HLA-B*51 allele determined at study entry. Unrelated controls (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>240) were randomly obtained from the national cadaveric donor database. Demographic and clinical features of the patients were recorded by attending physicians through a questionnaire.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Mean age of cases was 42 years old. Nineteen (55.8%) were male, and the mean age at diagnosis was 35 years old; twenty (58.8%) were Mestizos, 8 (23.5%) were Caucasian, and 6 (17.6%) were Amerindians. Thirteen (38.2%) of 34 cases were HLA-B*51 allele positive; 11 were heterozygous and 2 homozygous for the allele. Thirty-four (14.2%) of 240 controls were positive for the HLA-B*51 allele. The association between BD and HLA-B*51 allele was greater than that of control group (OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3.75; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0012).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The HLA-B*51 allele is strongly associated with BD in Argentinean patients. Our finding is consistent with previous studies indicating that the HLA-B*51 allele is an important susceptibility gene in BD regardless the geographical region and ethnicity.</p></span>"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0005"
"titulo" => "Objective"
]
1 => array:2 [
"identificador" => "abst0010"
"titulo" => "Methods"
]
2 => array:2 [
"identificador" => "abst0015"
"titulo" => "Results"
]
3 => array:2 [
"identificador" => "abst0020"
"titulo" => "Conclusions"
]
]
]
"es" => array:3 [
"titulo" => "Resumen"
"resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Evaluar la asociación entre el alelo HLA-B*51 y la enfermedad de Behçet (EB) en pacientes argentinos.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Incluimos en forma consecutiva 34 pacientes argentinos con diagnóstico definitivo de EB entre los meses de octubre de 2016 y marzo de 2017. Ninguno de los pacientes tenía el alelo HLA-B*51 determinado al inicio del estudio. Los controles no relacionados (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>240) se obtuvieron al azar de la base nacional de datos de donantes cadavéricos. Las características demográficas y clínicas de los pacientes fueron registradas por los médicos asistentes a través de un cuestionario.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">La edad promedio de los casos fue de 42 años. Diecinueve (55,8%) fueron varones, y la edad promedio en el momento del diagnóstico fue de 35 años; 20 (58,8%) fueron mestizos, 8 (23,5%) caucásicos y 6 (17,6%) amerindios. Trece (38,2%) de los 34 casos fueron positivos para el alelo HLA-B*51; 11 de ellos fueron heterocigotas y 2 homocigotas para dicho alelo. Treinta y cuatro (14,2%) de los 240 controles fueron positivos para el alelo HLA-B*51. La asociación entre la EB y el alelo HLA-B*51 fue mayor que en el grupo control (OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3,75; p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,0012).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">El alelo HLA-B*51 está fuertemente asociado con la EB en pacientes argentinos. Nuestro hallazgo es consistente con estudios previos que indican que el alelo HLA-B*51 es un gen de susceptibilidad importante en la EB independientemente de la región geográfica y la etnia.</p></span>"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0025"
"titulo" => "Objetivo"
]
1 => array:2 [
"identificador" => "abst0030"
"titulo" => "Métodos"
]
2 => array:2 [
"identificador" => "abst0035"
"titulo" => "Resultados"
]
3 => array:2 [
"identificador" => "abst0040"
"titulo" => "Conclusiones"
]
]
]
]
"multimedia" => array:3 [
0 => array:8 [
"identificador" => "tbl0005"
"etiqueta" => "Table 1"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at1"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">SD: standard deviation; yrs: years.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Features \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>34 \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Female/male; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">15/19 (44.12/55.88) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Age (yrs); mean (SD)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">42 (13.56) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Mean age at disease onset (yrs); mean (SD)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">35 (13.86) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Mean disease duration (yrs); median (range)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">15.87 (0–31.75) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Ethnic distribution; n (%)</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Mestizo \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">20 (58.82) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleHsp" style=""></span>White \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">8 (23.53) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Amerindian \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6 (17.65) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Oral ulcer; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">34 (100) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Cutaneous involvement; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">30 (88.24) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Erythema nodosum; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">12 (35.29) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Papulopustular lesions; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">22 (64.71) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Articular involvement; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">25 (73.53) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Genital ulcer; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">23 (67.65) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Eye involvement; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">22 (64.71) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Neurologic involvement; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">17 (50) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Headache; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">15 (44.12) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Generals symptoms; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">10 (29.41) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Deep vein thrombosis; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">5 (14.71) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">Epididymitis; n (%)</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">2 (5.88) \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab2333423.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Demographic and Clinical Features of 34 Argentinean Patients With Behçet's Disease.</p>"
]
]
1 => array:8 [
"identificador" => "tbl0010"
"etiqueta" => "Table 2"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at2"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">BD: Behçet’ disease; OR: odds ratio; CI: confidence interval.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">HLA-B*51 \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">BD patients<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>34 (%) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Controls<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>240 \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">OR (95% CI) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Present \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">13 (38.24) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">34 (14.16) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " rowspan="2" align="left" valign="middle">0.0012</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " rowspan="2" align="left" valign="middle">3.75 (1.71–8.19)</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Absent \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">21 (61.76) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">206 (85.84) \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab2333424.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Association of HLA-B*51 in Behçet's Disease Patients and Controls.</p>"
]
]
2 => array:8 [
"identificador" => "tbl0015"
"etiqueta" => "Table 3"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at3"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">BD: Behçet’ disease; OR: odds ratio; CI: confidence interval; n<span class="elsevierStyleSup">a</span>: number of alleles; a<span class="elsevierStyleSup">f</span>: allele frequencies.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Population \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">BD patientsn<span class="elsevierStyleSup">a</span> (a<span class="elsevierStyleSup">f</span>) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Controlsn<span class="elsevierStyleSup">a</span> (a<span class="elsevierStyleSup">f</span>) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">OR (95% CI) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Argentinean \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">15 (0.22) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">34 (0.07) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">0.0012 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">3.71 (1.89–7.26) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mexican Mestizo<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6 (0.09) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">10 (0.05) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">0.24 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">1.88 (0.58–5.93) \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab2333422.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">HLA-B*51 Allele Frequencies in Argentinean BD Patients, Mexican Mestizo BD Patients and Controls.</p>"
]
]
]
"bibliografia" => array:2 [
"titulo" => "<span class="elsevierStyleBold">References</span>"
"seccion" => array:1 [
0 => array:2 [
"identificador" => "bibs0015"
"bibliografiaReferencia" => array:18 [
0 => array:3 [
"identificador" => "bib0095"
"etiqueta" => "1"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Behçet's syndrome"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "C.G. Barnes"
1 => "H. Yazici"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1093/rheumatology/38.12.1171"
"Revista" => array:6 [
"tituloSerie" => "Rheumatology"
"fecha" => "1999"
"volumen" => "38"
"paginaInicial" => "1171"
"paginaFinal" => "1176"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/10587540"
"web" => "Medline"
]
]
]
]
]
]
]
]
1 => array:3 [
"identificador" => "bib0100"
"etiqueta" => "2"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Behçet disease"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "T. Sakane"
1 => "M. Takeno"
2 => "N. Suzuki"
3 => "G. Inaba"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "N Engl J Med"
"fecha" => "1999"
"volumen" => "341"
"paginaInicial" => "1284"
"paginaFinal" => "1291"
]
]
]
]
]
]
2 => array:3 [
"identificador" => "bib0105"
"etiqueta" => "3"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "HLA and non-HLA genes in Behçet disease: a multicentric study in the Spanish population"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "M.A. Montes-Cano"
1 => "M. Conde-Jaldón"
2 => "J.R. García-Lozano"
3 => "L. Ortiz-Fernández"
4 => "N. Ortego-Centeno"
5 => "M.J. Castillo-Palma"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1186/ar4328"
"Revista" => array:5 [
"tituloSerie" => "Arthritis Res Ther"
"fecha" => "2013"
"volumen" => "15"
"paginaInicial" => "R145"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/24286189"
"web" => "Medline"
]
]
]
]
]
]
]
]
3 => array:3 [
"identificador" => "bib0110"
"etiqueta" => "4"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "HL-A5 and Behçet's disease"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "S. Ono"
1 => "K. Aoki"
2 => "S. Sugiura"
3 => "E. Nakayama"
4 => "K. Itakura"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1016/s0140-6736(86)92019-2"
"Revista" => array:6 [
"tituloSerie" => "Lancet"
"fecha" => "1973"
"volumen" => "2"
"paginaInicial" => "1383"
"paginaFinal" => "1384"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/2878238"
"web" => "Medline"
]
]
]
]
]
]
]
]
4 => array:3 [
"identificador" => "bib0115"
"etiqueta" => "5"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Close association of HLA-Bw51 with Behçet's disease"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "S. Ohno"
1 => "M. Ohguchi"
2 => "S. Hirose"
3 => "H. Matsuda"
4 => "A. Wakisaka"
5 => "M. Aizawa"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1001/archopht.1982.01030040433013"
"Revista" => array:6 [
"tituloSerie" => "Arch Ophthalmol"
"fecha" => "1982"
"volumen" => "100"
"paginaInicial" => "1455"
"paginaFinal" => "1458"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/6956266"
"web" => "Medline"
]
]
]
]
]
]
]
]
5 => array:3 [
"identificador" => "bib0120"
"etiqueta" => "6"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "M. de Menthon"
1 => "M.P. Lavalley"
2 => "C. Maldini"
3 => "L. Guillevin"
4 => "A. Mahr"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1002/art.24642"
"Revista" => array:6 [
"tituloSerie" => "Arthritis Rheum"
"fecha" => "2009"
"volumen" => "61"
"paginaInicial" => "1287"
"paginaFinal" => "1296"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/19790126"
"web" => "Medline"
]
]
]
]
]
]
]
]
6 => array:3 [
"identificador" => "bib0125"
"etiqueta" => "7"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "D.H. Verity"
1 => "J.E. Marr"
2 => "S. Ohno"
3 => "G.R. Wallace"
4 => "M.R. Stanford"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1034/j.1399-0039.1999.540301.x"
"Revista" => array:6 [
"tituloSerie" => "Tissue Antigens"
"fecha" => "1999"
"volumen" => "54"
"paginaInicial" => "213"
"paginaFinal" => "220"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/10519357"
"web" => "Medline"
]
]
]
]
]
]
]
]
7 => array:3 [
"identificador" => "bib0130"
"etiqueta" => "8"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "C. Lavalle"
1 => "D. Alarcón-Segovia"
2 => "J.A. Del Guidice-Knipping"
3 => "A. Fraga"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Rhematol"
"fecha" => "1981"
"volumen" => "8"
"paginaInicial" => "325"
"paginaFinal" => "327"
]
]
]
]
]
]
8 => array:3 [
"identificador" => "bib0135"
"etiqueta" => "9"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:3 [
0 => "E. Soto Vega"
1 => "R. García-Muñoz"
2 => "Y. Richaud-Patin"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1016/j.imlet.2004.03.017"
"Revista" => array:7 [
"tituloSerie" => "Immunol Lett"
"fecha" => "2004"
"volumen" => "93"
"numero" => "2–3"
"paginaInicial" => "211"
"paginaFinal" => "215"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/15158619"
"web" => "Medline"
]
]
]
]
]
]
]
]
9 => array:3 [
"identificador" => "bib0140"
"etiqueta" => "10"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:1 [
"titulo" => "Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease"
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Lancet"
"fecha" => "1990"
"volumen" => "335"
"paginaInicial" => "1078"
"paginaFinal" => "1080"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/1970380"
"web" => "Medline"
]
]
]
]
]
]
]
]
10 => array:3 [
"identificador" => "bib0145"
"etiqueta" => "11"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "The GLADEL multinational Latin American prospective inception cohort of 1.214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:3 [
0 => "B.A. Pons-Estel"
1 => "L.J. Catoggio"
2 => "M.H. Cardiel"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Medicine (Baltimore)"
"fecha" => "2004"
"volumen" => "83"
"paginaInicial" => "1"
"paginaFinal" => "17"
]
]
]
]
]
]
11 => array:3 [
"identificador" => "bib0150"
"etiqueta" => "12"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Behçet's syndrome in 32 patients in Yorkshire"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "M.A. Chamberlain"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1136/ard.36.6.491"
"Revista" => array:6 [
"tituloSerie" => "Ann Rheum Dis"
"fecha" => "1977"
"volumen" => "36"
"paginaInicial" => "491"
"paginaFinal" => "499"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/596943"
"web" => "Medline"
]
]
]
]
]
]
]
]
12 => array:3 [
"identificador" => "bib0155"
"etiqueta" => "13"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "An immunogenetic basis for the tissue involvement in Behçet's syndrome"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "T. Lehner"
1 => "J.R. Batchelor"
2 => "S.J. Challacombe"
3 => "L. Kennedy"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Immunology"
"fecha" => "1979"
"volumen" => "37"
"paginaInicial" => "895"
"paginaFinal" => "900"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/500134"
"web" => "Medline"
]
]
]
]
]
]
]
]
13 => array:3 [
"identificador" => "bib0160"
"etiqueta" => "14"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "HL-A antigens in Behçet's disease"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "J.D. O’Duffy"
1 => "H.F. Taswell"
2 => "L.R. Elveback"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "J Rheumatol"
"fecha" => "1976"
"volumen" => "3"
"paginaInicial" => "1"
"paginaFinal" => "3"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/1271386"
"web" => "Medline"
]
]
]
]
]
]
]
]
14 => array:3 [
"identificador" => "bib0165"
"etiqueta" => "15"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Studies on HLA antigens in American patients with Behçet's disease"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "S. Ohno"
1 => "D.H. Char"
2 => "S.J. Kimura"
3 => "G.R. O’Connor"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Jpn J Ophthalmol"
"fecha" => "1978"
"volumen" => "22"
"paginaInicial" => "58"
"paginaFinal" => "61"
]
]
]
]
]
]
15 => array:3 [
"identificador" => "bib0170"
"etiqueta" => "16"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Primary association of HLA-B51 with Behçet's disease in Ireland"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "D.J. Kilmartin"
1 => "A. Finch"
2 => "R.W. Acheson"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Br J Ophthalmol"
"fecha" => "1997"
"volumen" => "81"
"paginaInicial" => "649"
"paginaFinal" => "653"
]
]
]
]
]
]
16 => array:3 [
"identificador" => "bib0175"
"etiqueta" => "17"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Dissimilar evolution of B-locus compared to A-locus and class II loci of the HLA region in South American Indian tribes"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:3 [
0 => "M. Fernández-Viña"
1 => "A.M. Lazaro"
2 => "C.Y. Marco"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1111/j.1399-0039.1997.tb02867.x"
"Revista" => array:6 [
"tituloSerie" => "Tissue Antigens"
"fecha" => "1997"
"volumen" => "50"
"paginaInicial" => "233"
"paginaFinal" => "250"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/9331946"
"web" => "Medline"
]
]
]
]
]
]
]
]
17 => array:3 [
"identificador" => "bib0180"
"etiqueta" => "18"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:3 [
0 => "P. Parham"
1 => "K.L. Arnett"
2 => "E.J. Adams"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1111/j.1399-0039.1997.tb02866.x"
"Revista" => array:6 [
"tituloSerie" => "Tissue Antigens"
"fecha" => "1997"
"volumen" => "50"
"paginaInicial" => "219"
"paginaFinal" => "232"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/9331945"
"web" => "Medline"
]
]
]
]
]
]
]
]
]
]
]
]
]
"idiomaDefecto" => "en"
"url" => "/1699258X/0000001600000004/v1_202007040724/S1699258X18301347/v1_202007040724/en/main.assets"
"Apartado" => array:4 [
"identificador" => "17499"
"tipo" => "SECCION"
"es" => array:2 [
"titulo" => "Originales"
"idiomaDefecto" => true
]
"idiomaDefecto" => "es"
]
"PDF" => "https://static.elsevier.es/multimedia/1699258X/0000001600000004/v1_202007040724/S1699258X18301347/v1_202007040724/en/main.pdf?idApp=UINPBA00004M&text.app=https://www.reumatologiaclinica.org/"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18301347?idApp=UINPBA00004M"
]